These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 9258277)

  • 1. Effects of heparin treatment on hemostatic abnormalities in obese non-insulin-dependent diabetic patients.
    Avellone G; di Garbo V; Cordova R; Rotolo G; Raneli G; de Simone R; Bompiani G
    Metabolism; 1997 Aug; 46(8):930-4. PubMed ID: 9258277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood coagulation and fibrinolysis in obese NIDDM patients.
    Avellone G; Di Garbo V; Cordova R; Rotolo G; Abruzzese G; Raneli G; De Simone R; Bompiani GD
    Diabetes Res; 1994; 25(2):85-92. PubMed ID: 7648783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired fibrinolytic compensation for hypercoagulability in obese patients with type 2 diabetes: association with increased plasminogen activator inhibitor-1.
    Aso Y; Matsumoto S; Fujiwara Y; Tayama K; Inukai T; Takemura Y
    Metabolism; 2002 Apr; 51(4):471-6. PubMed ID: 11912556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemostatic variables, carbohydrate metabolism and lipid profile in women with low body mass index.
    Polac I; Stachowiak G; Jedrzejczyk S; Stetkiewics T; Sobieszczanska S; Pertynski T
    Gynecol Endocrinol; 2003 Apr; 17(2):151-7. PubMed ID: 12744226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase in both pro-thrombotic and anti-thrombotic factors in obese premenopausal women: relationship with body fat distribution.
    De Pergola G; De Mitrio V; Giorgino F; Sciaraffia M; Minenna A; Di Bari L; Pannacciulli N; Giorgino R
    Int J Obes Relat Metab Disord; 1997 Jul; 21(7):527-535. PubMed ID: 9226481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects.
    Kruszynska YT; Yu JG; Olefsky JM; Sobel BE
    Diabetes; 2000 Apr; 49(4):633-9. PubMed ID: 10871202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NIDDM in the elderly.
    Meneilly GS; Elliott T; Tessier D; Hards L; Tildesley H
    Diabetes Care; 1996 Dec; 19(12):1320-5. PubMed ID: 8941457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship among TAFI, t-PA, PAI-1 and F1 + 2 in type 2 diabetic patients with normoalbuminuria and microalbuminuria.
    Chudý P; Kotuličová D; Staško J; Kubisz P
    Blood Coagul Fibrinolysis; 2011 Sep; 22(6):493-8. PubMed ID: 21519232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulation, fibrinolysis and haemorheology in premenopausal obese women with different body fat distribution.
    Avellone G; Di Garbo V; Cordova R; Raneli G; De Simone R; Bompiani G
    Thromb Res; 1994 Aug; 75(3):223-31. PubMed ID: 7992233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients.
    McGill JB; Schneider DJ; Arfken CL; Lucore CL; Sobel BE
    Diabetes; 1994 Jan; 43(1):104-9. PubMed ID: 8262307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Indirect comparison of changes of parameters of hemostasis during short-term use of ticlopidine and clopidogrel in patients with non-ST elevation acute coronary syndrome].
    Slavina NN; Averkov OV; Gratsianskiĭ NA
    Kardiologiia; 2005; 45(12):11-6. PubMed ID: 16353041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lower androgenicity is associated with higher plasma levels of prothrombotic factors irrespective of age, obesity, body fat distribution, and related metabolic parameters in men.
    De Pergola G; De Mitrio V; Sciaraffia M; Pannacciulli N; Minenna A; Giorgino F; Petronelli M; Laudadio E; Giorgino R
    Metabolism; 1997 Nov; 46(11):1287-93. PubMed ID: 9361687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coagulation and fibrinolysis parameters in type 2 diabetic patients with and without diabetic vascular complications.
    Erem C; Hacihasanoğlu A; Celik S; Ovali E; Ersöz HO; Ukinç K; Deger O; Telatar M
    Med Princ Pract; 2005; 14(1):22-30. PubMed ID: 15608477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex differences in coagulation and fibrinolysis in white subjects with non-insulin-dependent diabetes mellitus.
    Mansfield MW; Heywood DM; Grant PJ
    Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):160-4. PubMed ID: 8548417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen activator inhibitor-1 and tissue-plasminogen activator in minority adolescents with type 2 diabetes and obesity.
    Umpaichitra V; Hussain MM; Castells S
    Pediatr Res; 2005 Sep; 58(3):483-7. PubMed ID: 15901895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of 17 beta-oestradiol on variables of coagulation and fibrinolysis in postmenopausal women with type 2 diabetes mellitus.
    Brussaard HE; Leuven JA; Krans HM; Kluft C
    Vascul Pharmacol; 2002 Aug; 39(3):141-7. PubMed ID: 12616982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of obesity on insulin resistance in normal subjects and patients with NIDDM.
    Ludvik B; Nolan JJ; Baloga J; Sacks D; Olefsky J
    Diabetes; 1995 Sep; 44(9):1121-5. PubMed ID: 7657038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of oestrogen replacement therapy on haemostatic variables in postmenopausal women with non-insulin-dependent diabetes mellitus.
    Hahn L; Mattsson LA; Andersson B; Tengborn L
    Blood Coagul Fibrinolysis; 1999 Mar; 10(2):81-6. PubMed ID: 10192656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemostatic function in young subjects with central obesity: relationship with left ventricular function.
    Licata G; Scaglione R; Avellone G; Ganguzza A; Corrao S; Arnone S; Di Chiara T
    Metabolism; 1995 Nov; 44(11):1417-21. PubMed ID: 7476328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.